Inari Medical, Inc. is a medical device company. The Companyâs products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.

Employees

1,300

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

Market Closed - Nasdaq Other stock markets 04:00:00 2025-02-18 pm EST			5-day change	1st Jan Change
79.97 ^USD	+0.05%		-.--%	-

25-07-29	Inari Medical Launches the All-New InThrill®? Thrombectomy System, Designed to Addressarteriovenous Access and Small Vessel Thrombus Cases	CI
25-03-06	Inari Medical Launches Artix Thrombectomy System	CI

Capitalization	2.99B 2.54B 2.36B 2.2B 4.1B 275B 4.35B 26.93B 10.69B 130B 11.21B 10.98B 472B	P/E ratio 2022	-115x	P/E ratio 2023	-2,164x
Enterprise value	2.91B 2.47B 2.29B 2.14B 3.99B 267B 4.23B 26.17B 10.39B 126B 10.89B 10.67B 458B	EV / Sales 2022	8.13x	EV / Sales 2023	7.41x
Free-Float	91.26%	Yield 2022 *	-	Yield 2023	-

25-07-29	Inari Medical Launches the All-New InThrill®? Thrombectomy System, Designed to Addressarteriovenous Access and Small Vessel Thrombus Cases	CI
25-03-06	Inari Medical Launches Artix Thrombectomy System	CI
25-02-19	Stryker Completes Acquisition of Inari Medical	MT
25-02-18	Inari Medical, Inc.(NasdaqGS:NARI) dropped from NASDAQ Composite Index	CI
25-02-18	Stryker Corporation complete the acquisition of Inari Medical, Inc..	CI
25-02-18	Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P TMI Index	CI
25-02-18	Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P Healthcare Equipment Select Industry Index	CI
25-02-18	Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P Global BMI Index	CI
25-02-18	Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P Composite 1500	CI
25-02-18	Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P 1000	CI
25-02-18	Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P 600	CI
25-02-18	Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P 600 Health Care	CI
25-02-14	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Ahead of More Economic Reports	MT

25-01-08	BTIG Downgrades Inari Medical to Neutral From Buy	MT
25-01-07	Jefferies Downgrades Inari Medical to Hold From Buy, $80 Price Target	MT
25-01-07	Canaccord Genuity Downgrades Inari Medical to Hold From Buy, Adjusts Price Target to $80 From $74	MT
25-01-07	Baird Downgrades Inari Medical to Neutral From Outperform, Trims Price Target to $80 From $81	MT
25-01-07	William Blair Downgrades Inari Medical to Market Perform From Outperform	MT

Inari Medical, Inc. Stock

Equities

NARI

US45332Y1091

Medical Equipment, Supplies & Distribution

Valuation: Inari Medical, Inc.

Chart: Inari Medical, Inc.

Latest news: Inari Medical, Inc.

Analysts' recommendations: Inari Medical, Inc.

Press Releases: Inari Medical, Inc.

News in other languages: Inari Medical, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Inari Medical, Inc.

Medical Equipment

Financials

Company Profile

Income Statement and Estimates

25-01-20	Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.	AQ
25-01-07	INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARI	BU
25-01-07	$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Inari Medical, Inc. - NARI	PR
25-01-06	NARI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inari Medical, Inc. Is Fair to Shareholders	BU
25-01-06	Inari Medical to Present at the J.P. Morgan Healthcare Conference	AQ

25-01-12	J&J estudia una oferta por Intra-Cellular Therapies, informa Bloomberg News
25-01-07	MÄRKTE USA/Technologiesektor führt Abgaben an Wall Street an
25-01-07	MÄRKTE USA/Technologiewerte führen Abwärtsbewegung an Wall Street an
25-01-07	Medtech : Stryker rachète Inari pour 4,9 milliards de dollars
25-01-07	En direct des marchés : Sodexo démarre piano piano, Julius Bär s'allège, Tencent et CATL tricards

1 year	79.55	79.99
3 years	36.73	79.99
5 years	36.73	127.42
10 years	36.73	127.42

Manager	Title	Age	Since
Kevin Strange DFI	Director of Finance/CFO	-	2024-09-30
Norman Nie CTO	Chief Tech/Sci/R&D Officer	-	2019-03-31
Shon Chakrabarti CTO	Chief Tech/Sci/R&D Officer	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
INARI MEDICAL, INC.	+0.05%	-.--%	+0.64%	+27.97%	4.7B
PENUMBRA, INC.	+0.20%	+2.42%	+31.22%	+43.34%	14.07B
SHOCKWAVE MEDICAL	-0.01%	+0.01%	+0.01%	+89.32%	12.57B
MASIMO CORPORATION	-1.72%	-0.42%	-15.84%	-18.12%	7.6B
GETINGE AB	0.00%	-5.08%	+6.13%	-11.60%	6.38B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+0.81%	+1.60%	+18.01%	+30.02%	5.9B
APT MEDICAL INC.	+1.48%	-3.69%	-5.72%	+42.53%	4.91B
ASAHI INTECC CO., LTD.	-0.07%	-4.50%	+6.83%	+25.67%	4.71B
CHEMOMETEC A/S	-2.77%	-3.93%	+35.04%	+6.29%	1.88B
SHANDONG WEIGAO ORTHOPAEDIC DEVICE CO., LTD	+3.09%	+3.95%	+22.37%	-50.34%	1.79B
Average	+0.11%	-0.59%	+9.87%	+18.51%	6.45B
Weighted average by Cap.	+0.03%	-0.12%	+8.95%	+32.26%

	2022	2023
Net sales	383M 326M 302M 282M 527M 35.23B 558M 3.45B 1.37B 16.63B 1.44B 1.41B 60.51B	494M 420M 389M 364M 678M 45.35B 719M 4.45B 1.77B 21.41B 1.85B 1.81B 77.89B
Net income	-29.27M -24.89M -23.07M -21.56M -40.19M -2.69B -42.6M -264M -105M -1.27B -110M -107M -4.62B	-1.64M -1.39M -1.29M -1.21M -2.25M -150M -2.38M -14.74M -5.85M -70.97M -6.13M -6.01M -258M
Net Debt	-294M -250M -232M -217M -404M -27.02B -428M -2.65B -1.05B -12.76B -1.1B -1.08B -46.41B	-83.4M -70.94M -65.75M -61.44M -115M -7.66B -121M -751M -298M -3.62B -313M -306M -13.16B